NCT06788847

Brief Summary

This study aims to evaluate the efficacy and safety of ultrasound-guided needle knife dissection in treating Dupuytren's contracture. The procedure is designed to improve hund function and minimize complications associated with the conventional surgical methods.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

January 19, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 23, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 19, 2026

Completed
Last Updated

January 27, 2025

Status Verified

January 1, 2025

Enrollment Period

6 months

First QC Date

January 17, 2025

Last Update Submit

January 23, 2025

Conditions

Keywords

Ultrasound-Guided ProcedureDupuytrene's ContractureTubiana GradeFibrotic Cords AcupotomyFunctional Hand RecoveryPalmar Fascia Fibrosis

Outcome Measures

Primary Outcomes (2)

  • Improvement in hand Function

    Functional Improvement: \- Evaluated using the QuickDASH score (0-100 scale).

    6 months

  • Improvement in hand mobility

    Range of Motion (ROM): \- Measurment of joint mobility in degrees at MCP and PIP joints by goniometer.

    6 months

Secondary Outcomes (2)

  • Patient Satisfaction

    6 months

  • Rate of procedure-related complications

    6 months

Study Arms (1)

Intervention Group: Ultrasound-Guided Needle Knife Dissection

EXPERIMENTAL

Participants in this group will undergo ultrasound-guided needle knife dissection for the treatment of Dupuytren's Contracture. Local anesthesia using 3-5ml of 1% lidocaine 0.25% bupivacaine is administered for patient comfort. This procedure is designed to improve hand function with minimal complications.

Procedure: Ultrasound guided needle knife dissection

Interventions

This procedure involves a minimally invasive dissection of the fibrous cords in Dupuytren's Contracture using a needle knife guided by ultrasound imaging. Local anesthesia using 3-5 ml of 1% Lidocaine and 0.25% bupivacaine is administered for patient comfort. The technique aims to improve precision, minimize complications and reduce recurrence. Device: Sonosite M-Turbo Ultrasound Machine with Linear Probe HFL38x (6-13 MHz) is used for real-time imaging during the procedure.

Also known as: UGNK procedure
Intervention Group: Ultrasound-Guided Needle Knife Dissection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants diagnosed with Dupuytren's Contracture.
  • Willing to undergo ultrasound-guided needle knife dissection

You may not qualify if:

  • Patients who have undergone previous surgery or needle apponeurotomy for Dupuytren's Contracture on the same hand.
  • Active hand infections, open wounds, or dermatological conditions in the treatment area.
  • Coagulopathy or use of anticoagulant that cannot be safely paused
  • Neuromuscular disorders affecting hand function
  • Pregnancy or breastfeeding
  • Uncontrolled systemic illnesses, such as poorly managed diabetes or cardiovascular disease.
  • Known hypersensitivity to local anesthetics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Hospital

Al Mansurah, Dakahlia Governorate, 35516, Egypt

RECRUITING

MeSH Terms

Conditions

Dupuytren Contracture

Condition Hierarchy (Ancestors)

FibromaNeoplasms, Fibrous TissueNeoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasmsContractureMuscular DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Mohamed Maher Elashmawy, MD, PHD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All participants will undergo ultrasound-guided needle knife dissection for Dupuytren's Contracture treatment.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of Rheumatology, Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

January 17, 2025

First Posted

January 23, 2025

Study Start

January 19, 2025

Primary Completion

July 19, 2025

Study Completion

January 19, 2026

Last Updated

January 27, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

The individual participant data (IPD) will not be shared to ensure participant confidentiality and comply with ethical and institutional regulations. The collected data will only be used for the purposes of this study and will not be disclosed to external parties

Locations